Dr Ruth KM Pfau civil hospital karachi
Karachi, Sindh, 74200, Pakistan
NCT Number: NCT06044519
The goal of this clinical trial] is to compare different types of dressings used and there outcomes on STSG donor site wound. The main question[s] it aims to answer are:
* the effectiveness of different donor site dressings and their adverse outcomes * the satisfaction of patients with the donor site dressing will be observed. Participants will randomly allocated different types of dressings for split thickness skin graft donor site wound which include alginate hydrocolloid hydrofiber silicon film guaze
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Karachi, Sindh, 74200, Pakistan
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
different types of dressings were compared ti see the effectiveness for for STSG donor site wound
Time frame: six month
scaring by POSAS SCORE, pain and itcting by VISUAL ANALOGUE SCAORE.
Time frame: six months
likert scale
Time frame: six months
infection, hypergranulation, allergy
Dow University of Health Sciences
Other
A Single Centre Randomized Control Trial of Donor Site Wound Dressing After Split Thickness Skin Grafting
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04403503
Donor Site Complication
Ankara, Turkey (Türkiye)
View Trial DetailsNCT04050124
Donor Site Complication, Skin Graft Disorder
New York, United States
View Trial DetailsNCT04692961
Donor Site Complication, Ischemia
Douliu, Yunlin County, Taiwan
View Trial DetailsNCT02737748
Donor Site Complication
Tokyo, Japan
View Trial Details